Trials / Active Not Recruiting
Active Not RecruitingNCT05603468
Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair
Effect of Platelet-Rich Plasma vs Corticosteroid Injection in Distinct Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair: a Multicenter, Three-group, Randomized Controlled Trial
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 387 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multicenter, randomized, single-blinded, parallel group,placebo-controlled,three-group establishment of specific treatment regimen for subtypes of tendinopathy
Detailed description
This clinical trial uses machine learning to match molecular and clinical features,so as to establish a "rapid recognition system of tendinopathy subtypes" and compares the clinical effects of corticosteroid,platelet rich plasma or placebo on different subtypes of tendinopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | platelet rich plasma | Platelet rich plasma group: after the surgery of rotator arthroscopic rotator cuff repair, 3ml PRP (LongTai Biological Company) was injected into the rotator cuff tear under the rotator arthroscope for a time. PRP production process: before anesthesia, 20ml arterial blood was drawn and injected into the PRP tube. The blood was fully oscillated in the tube, and then placed in a centrifuge with 1500g for 9min to remove excess plasma and make 5ml PRP. 3ml is used for injection and 2ml is used for quality control. |
| DRUG | Corticosteroid | Corticosteroid group: after the surgery of rotator cuff repair under arthroscopy, 1mL prednisone (MSD) + 2mL sodium hyaluronate (biochemical Industry Co., Ltd.) was injected under arthroscopy. |
| DRUG | Normal saline | Normal saline |
Timeline
- Start date
- 2022-12-15
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
- First posted
- 2022-11-02
- Last updated
- 2026-02-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05603468. Inclusion in this directory is not an endorsement.